Attached files
file | filename |
---|---|
S-1/A - S-1/A - Karyopharm Therapeutics Inc. | a2220615zs-1a.htm |
EX-1.1 - EX-1.1 - Karyopharm Therapeutics Inc. | a2220615zex-1_1.htm |
EX-5.1 - EX-5.1 - Karyopharm Therapeutics Inc. | a2220615zex-5_1.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Amendment No.1 to the Registration Statement (No. 333-196892) on Form S-1 of Karyopharm Therapeutics Inc. of our report dated March 21, 2014, relating to our audit of the consolidated financial statements, which appears in the Annual Report on Form 10-K of Karyopharm Therapeutics Inc. for the year ended December 31, 2013.
We also consent to the reference to our Firm under the caption "Experts" in the Prospectus, which is part of this Registration Statement.
/s/ McGladrey LLP
Boston,
Massachusetts
June 25, 2014
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM